Table 4.
Studies reporting on other medical conditions post-FMT.
| Author | Onset of New Medical Condition * Patients (%) | Deterioration of Medical Condition ** Patients (%) | Amelioration of Medical Condition ** Patients (%) |
|---|---|---|---|
| Perler et al. [20] | 105 (51%) | 11 (5%) | 15 (7%) |
| Infectious disorders: n = 84 | |||
| AD: n = 3 | Rheumatoid arthritis: n = 1 | IBS: n = 10 | |
| Malignancies: n = 8 | IBD: n = 4 | ||
| IBD/IBS: n = 12 | IBD: n = 10 | Alopecia areata: n = 1 | |
| Other: n = 33 | |||
| Lee et al. [18] | 8 (35%) | Not available | 7 (30%) |
| Infectious disorders: n = 0 | IBD: n = 4 | ||
| AD: n = 1 | Diabetes mellitus: n = 1 | ||
| Malignancies: n = 1 | Parkinson’s disease: n = 2 | ||
| IBD/IBS: n = 2 | |||
| Other: n = 4 | |||
| Mamo et al. [19] | 43 (31%) | Not available | 12 (7%) |
| Rheumatoid arthritis: n = 1 | |||
| Infectious disorders: n = 1 | IBS: n = 3 | ||
| Autoimmune disorders: n = 0 | IBD: n = 2 | ||
| Malignancies: n = 1 | Diverticulosis: n = 2 | ||
| IBD/IBS: n = 0 | Diabetes mellitus: n = 1 | ||
| Other: n = 40 | CVID: n = 1 | ||
| Jalanka et al. [17] | 16 (29%) | 4 (7%) | 8 (11%) |
| Infectious disorders: n = 0 | |||
| AD: n = 1 | Diabetes mellitus: n = 2 | IBD: n = 5 | |
| Malignancies: n = 0 | |||
| IBD/IBS: n = 5 | AD: n = 2 | AD: n = 3 | |
| Other: n = 10 |
* All new-onset medical conditions reported in footnote. ** Medical conditions present before FMT. Abbreviations: AD = autoimmune disease, CVID: common variable immunodeficiency, IBD = inflammatory bowel disease, IBS = irritable bowel disease.